European Journal of Pediatrics

, Volume 162, Issue 12, pp 820–827

Patterns and perceptions of complementary/alternative medicine among paediatricians and patients' mothers: a review of the literature

  • Laura Cuzzolin
  • Silvana Zaffani
  • Vitalia Murgia
  • Michele Gangemi
  • Giorgio Meneghelli
  • Giampietro Chiamenti
  • Giuseppina Benoni
Review

Abstract

For many families and their children, the use of complementary/alternative medicine (CAM) is an accepted adjunct or alternative to conventional therapy, even if data available in the literature regarding risks and adverse drug reactions (ADRs) pertaining to childhood populations are scarce. Moreover, despite widespread and increasing use of CAM, there are limited data on how paediatricians communicate with mothers and/or patients about CAM. Therefore, we report the studies available in the literature in the paediatric field and summarise what is known about ADRs and risks of CAM, taking into account in particular problems related to interactions between phytotherapy and conventional medicines and to counselling. Conclusion:from the analysis of the literature, some interesting aspects emerge: (1) the extent of CAM use in the paediatric field is increasingly sought by parents of children with chronic illnesses; (2) most parents who choose CAM medicine for their children believe that these therapies are "natural" and thus "safe" and (3) physicians often feel to know too little about CAM and wish to learn more for different reasons including "to dissuade whether the alternative method is unsafe and/or ineffective". Therefore, paediatricians should be prepared to discuss alternative therapies with parents, since talking about CAM may help to minimise the risks and to restrain parental misconceptions and doubts. Educational interventions for parents should also be performed to bring about a more aware use of traditional and alternative medicines.

Keywords

Children Mothers Complementary/alternative medicine Communication Paediatricians Side-effects 

Abbreviations

ADR

adverse drug reaction

CAM

complementary/alternative medicine

References

  1. 1.
    Abebe W (2002) Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 27: 391–401CrossRefPubMedGoogle Scholar
  2. 2.
    Andrews L, Lokuge S, Sawyer M, Lillywhite L, Kennedy D, Martin J (1998) The use of alternative therapies by children with asthma: a brief report. J Pediatr Child Health 34: 131–134Google Scholar
  3. 3.
    Anonymous (1986) Pancreatitis following ingestion of a homeopathic preparation. N Engl J Med 314: 1642Google Scholar
  4. 4.
    Anonymous (1994) Quincke's oedem bij gebruik van oester-extract in Ostrin plus GTZ 611. Gebu Prikbord 28: 67Google Scholar
  5. 5.
    Anonymous (1995) Propolis-recalled because of lead contamination. WHO Pharm Newslett 1: 3Google Scholar
  6. 6.
    Armishaw J, Grant CC (1999) Use of complementary treatment by those hospitalised with acute illness. Arch Dis Child 81: 133–137PubMedGoogle Scholar
  7. 7.
    Awang DVC (1991) Maternal use of ginseng and neonatal androgenization. JAMA 266: 363Google Scholar
  8. 8.
    Bakerink JA, Gospe SM, Dimand RJ, Eldridge MW (1996) Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics 98: 944–947PubMedGoogle Scholar
  9. 9.
    Bensoussan A (1999) Complementary medicine. Where lies its appeal? Med J Aust 170: 247–248PubMedGoogle Scholar
  10. 10.
    Bouraoui A, Toumi A, Bouchacha S, Boukef K, Brazier JL (1986) Influence de l'alimentation epicee et piquante sur l'asorption de la theophylline. Therapie 41: 467–471PubMedGoogle Scholar
  11. 11.
    But PPH (1994) Herbal poisoning caused by adulterants or erroneous substitutes. J Trop Med Hyg 97:371–374Google Scholar
  12. 12.
    Canduela V, Mongil I, Carrascosa M, Docio S, Cagisgas P (1995) Garlic: always good for the health? (letter). Br J Dermatol 132: 161–162PubMedGoogle Scholar
  13. 13.
    Chavis L (2001) Pharmacy-based consulting on dietary supplements. J Am Pharm Assoc 41: 181–191Google Scholar
  14. 14.
    Chen MF, Shimada F, Kato H, Yano S, Kanaoka M (1991) Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Endocrinol Jpn 38: 167–175PubMedGoogle Scholar
  15. 15.
    Chow RC (2000) Complementary medicine impact on medical practice. Curr Ther 7: 77–79Google Scholar
  16. 16.
    Clark RF, Strukle E, Williams SR, Manoguerra AS (1996) Selenium poisoning from a nutritional supplement. JAMA 275: 1087–1088Google Scholar
  17. 17.
    Corbin-Winslow L, Shapiro H (2002) Physicians want education about complementary and alternative medicine to enhance communication with their parents. Arch Intern Med 162: 1176–1181CrossRefPubMedGoogle Scholar
  18. 18.
    D'Arcy PF (1994) l -Tryptophan (Optimax): limited availability for resistant depression. Int Pharm J 8: 56Google Scholar
  19. 19.
    Day AS (2002) Use of complementary and alternative therapies and probiotic agents by children attending gastroenterology outpatient clinics. J Pediatr Child Health 38: 343–346CrossRefGoogle Scholar
  20. 20.
    De Smet PAGM (1992) Giftige metalen in homeopathische preparaten. Pharm Weekbl 127: 125–126Google Scholar
  21. 21.
    De Smet PAGM (1995) Health risks of herbal remedies. Drug Saf 13: 81–93PubMedGoogle Scholar
  22. 22.
    Dietary Supplement Health and Education Act (1994) Publication nr. 103–417, 108 Stat 4325Google Scholar
  23. 23.
    Donnelly WJ, Spykerboer JE, Thong YH (1985) Are patients who use alternative medicine dissatisfied with orthodox medicine? Med J Aust 142: 539–541PubMedGoogle Scholar
  24. 24.
    Eisenberg DM (1997) Advising patients who seek alternative medical therapies. Ann Int Med 127: 61–69Google Scholar
  25. 25.
    Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. N Engl J Med 328: 246–252PubMedGoogle Scholar
  26. 26.
    Ernst E (1995) The risks of acupuncture. Int J Risk Safety Med 6: 179–186Google Scholar
  27. 27.
    Ernst E (1999) Prevalence of complementary/alternative medicine for children: a systematic review. Eur J Pediatr 158: 7-11PubMedGoogle Scholar
  28. 28.
    Ernst E (2000) Risks associated with complementary therapies. In: Dukes MNG, Aronson JK (eds) Meyler's side effects of drugs, 14th edition. Elsevier, Amsterdam, pp 1649–1681Google Scholar
  29. 29.
    Ernst E, De Smet PAGM (1996) Risks associated with complementary therapies. In: Duke MNG (ed) Meyler's side effects of drugs, 13th edition. Elsevier Science, Amsterdam, pp 1427–1454Google Scholar
  30. 30.
    Ernst E, Dixon M (1997) Talking about the alternatives. Update 7 May: 632–634Google Scholar
  31. 31.
    Ernst E, White A (2000) The BBC survey of complementary medicine use in UK. Complement Ther Med 8: 32–36PubMedGoogle Scholar
  32. 32.
    Ernst E, Resch KL, Mills S, Hill R, Mitchell A, Willoughby M, White A (1995) Complementary medicine – a definition. Br J Gen Pract 45: 506PubMedGoogle Scholar
  33. 33.
    Ernst E, Resch KL, White AR (1995) Complementary medicine. What physicians think of it: a meta-analysis. Arch Int Med 155: 2405–2408CrossRefGoogle Scholar
  34. 34.
    Fisher P, Ward A (1994) Medicine in Europe: complementary medicine in Europe. BMJ 309: 107–111PubMedGoogle Scholar
  35. 35.
    Fugh-Berman A (2000) Herb-drug interactions. Lancet 355: 134–138PubMedGoogle Scholar
  36. 36.
    Fusco F, Sambugaro D, Bozzetti R (1998) La mamma colta sceglie una strada alternativa. Occhio Clinico Pediatria 9: 24–26Google Scholar
  37. 37.
    Garty B (1993) Garlic burns. Pediatrics 91: 658–659PubMedGoogle Scholar
  38. 38.
    Goldbeck-Wood S, Dorozynski A, Lie LG, Yamauchi M, Zinn C, Josefson D, Ingram M (1996) Complementary medicine is booming worldwide. BMJ 313: 131–133PubMedGoogle Scholar
  39. 39.
    Gordon J (1998) SSRIs and St John's wort: possible toxicity? Am Fam Phys 57: 950–953Google Scholar
  40. 40.
    Haines AP, Sanders TAB, Imerson JD (1986) Effects of fish oil supplement on platelet function, homeostatic variables and albuminuria in insulin-dependent diabetics. Thromb Res 43: 643–655PubMedGoogle Scholar
  41. 41.
    Hernandez-Reif M, Field T, Krasnegor J, Martinez E, Schwartzman M, Mavunda K (1999) Children with cystic fibrosis benefit from massage therapy. J Pediatr Psychol 24: 175–181CrossRefPubMedGoogle Scholar
  42. 42.
    Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, Tolia V, Bousvaros A (2002) Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 97: 382–388CrossRefPubMedGoogle Scholar
  43. 43.
    Horowitz RS, Gomez H, Moore LL, Fulton B, Feldhaus K, Brent J, Stermitz FR, Beck JJ, Alessi JR, De Smet PAGM (1993) Jin Bu Huan toxicity in children. Colorado 1993. Mor Mortal Wkly Rep 42: 633–636Google Scholar
  44. 44.
    Huang WF, Wen KC, Hsiao ML (1997) Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 37: 344–350Google Scholar
  45. 45.
    Hylck EM, Heiman H, Skates SJ, Sheehan MA, Singer DE (1998) Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 279: 657–662PubMedGoogle Scholar
  46. 46.
    Karliova M, Treichel U, Malago M, Frilling A, Gerken G, Broelsch CE (2000) Interaction of Hypericum perforatum (St John's wort) with cyclosporine A metabolism in a patient after liver transplantation. J Hepatol 33: 853–855CrossRefPubMedGoogle Scholar
  47. 47.
    Kerr HD, Saryan LA (1986) Arsenic content of homeopathic medicines. Clin Toxicol 24: 451–459Google Scholar
  48. 48.
    Ko RJ (1998) Adulterants in Asian patent medicines. N Engl J Med 339: 847CrossRefGoogle Scholar
  49. 49.
    Koopman H (1937) Tödliche Schöllkraut-Vergiftung ( Chelidonium majus). Vergiftungsf lle 8: 93–98Google Scholar
  50. 50.
    Lewis T (2001) Dear health professional colleague-letter. Rockville, MD: US Food and Drug Administration. Available from:http://www.fda.org/medwatch/safety/2001/kava.htm Google Scholar
  51. 51.
    Lininger SW, Gaby AR, Batz F, Yarnell E, Brown DJ, Constantine G (1999) A-Z guide to drug-herb-vitamin interactions. Prima Publishing, RocklineGoogle Scholar
  52. 52.
    MacLennan AH, Wilson DH, Taylor AW (1996) Prevalence and cost of alternative medicine in Australia. Lancet 347: 569–573PubMedGoogle Scholar
  53. 53.
    Mangione-Smith R, McGlynn EA, Elliott MN, Krogstad P, Brook RH (1999) The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics 103: 711–718PubMedGoogle Scholar
  54. 54.
    Mason S, Tovey P, Long AF (2002) Evaluating complementary medicine: methodological challenges of randomised controlled trials. BMJ 325: 832–834CrossRefPubMedGoogle Scholar
  55. 55.
    Menniti-Ippolito F, Gargiulo L, Bologna E, Forcella E, Raschetti R (2002) Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol 58: 61–64Google Scholar
  56. 56.
    Miller LG (1998) Herbal medicinals: selected clinical considerations focusing on potential herb-drug interactions. Arch Int Med 158: 2200–2211CrossRefGoogle Scholar
  57. 57.
    Miller LG, Hume A, Harris IM, Jackson EA, Kanmaz TJ, Cauffield JS, Chin TW, Knell M (2000) White paper on herbal products. Am Coll Clin Pharm Pharmacother 20: 877–891Google Scholar
  58. 58.
    Nebel A, Schneider BJ, Baker RK, Kroll DJ (1999) Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother 33: 502PubMedGoogle Scholar
  59. 59.
    Oepen I (1983) Kritische Argumente zur Homoopathie. Dtsch Apoth Ztg 123: 1105Google Scholar
  60. 60.
    Roulet M, Laurini R, Rivier L, Calame A (1988) Hepatic veno-occlusive disease in a newborn infant of a woman drinking herbal tea. J Pediatr 112: 433–436PubMedGoogle Scholar
  61. 61.
    Rowin J, Lewis SL (1997) Spontaneous bilateral subdural hematomas associated with chronic Gingko biloba ingestion. Neurology 48: 1775–1776Google Scholar
  62. 62.
    Shenfield G, Lim E, Allen H (2002) Survey of the use of complementary medicines and therapies in children with asthma. J Pediatr Child Health 38: 252–257CrossRefGoogle Scholar
  63. 63.
    Sibinga E, Ottolini M, Duggan A, Wilson M (2000) Communication about complementary/alternative medicine use in children. Pediatr Res 47: 226AGoogle Scholar
  64. 64.
    Simpson N, Roman K (2001) Complementary medicine use in children: extent and reasons. A population-based study. Br J Gen Pract 51: 914–916PubMedGoogle Scholar
  65. 65.
    Sorisky A, Robbins DC (1989) Fish oil and diabetes. The net effect. Diabetes Care 12:302–304PubMedGoogle Scholar
  66. 66.
    Southwood TR, Malleson PN, Roberts-Thomson PJ, Mahy M (1990) Unconventional remedies used for patients with juvenile arthritis. Pediatrics 85: 150–154PubMedGoogle Scholar
  67. 67.
    Spigelblatt LS, Laine-Ammara G, Pless IB, Guyver A (1994) The use of alternative medicine by children. Pediatrics 94: 811–814PubMedGoogle Scholar
  68. 68.
    Taylor RFH, Al-Jarad N, John LME (1992) Betel-nut chewing and asthma. Lancet 339: 1134–1136PubMedGoogle Scholar
  69. 69.
    Thompson RJ, Gustafson KE, Hamlett KW, Spock A (1992) Psychological adjustment of children with cystic fibrosis: the role of child cognitive processes and maternal adjustment. J Pediatr Psychol 17: 741–755PubMedGoogle Scholar
  70. 70.
    Trapani G, Barbato C, Zanino L, Del Giudice A, Liverani A (2002) Uso delle medicine non convenzionali nella popolazione pediatrica dell'Italia nord-occidentale. Available from:http://www.smbitalia.org/ricercaepidemio.html Google Scholar
  71. 71.
    Vaes LPJ, Chyka RA (2000) Interactions of warfarin with garlic, ginger, gingko or ginseng: nature of the evidence. Ann Pharmacother 34: 478–482CrossRefGoogle Scholar
  72. 72.
    Westendorf J (1992) Anthranoid derivatives – general discussion. In: De Smet PAGM, Keller K, Hansel R, Chandler RF (eds) Adverse effects of herbal drugs, vol. 2. Springer, Heidelberg Berlin New York, pp 105–108Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Laura Cuzzolin
    • 1
  • Silvana Zaffani
    • 1
  • Vitalia Murgia
    • 2
  • Michele Gangemi
    • 2
  • Giorgio Meneghelli
    • 2
  • Giampietro Chiamenti
    • 2
  • Giuseppina Benoni
    • 1
  1. 1.Department of Medicine and Public Health, Section of PharmacologyUniversity of Verona, Policlinico G.B. Rossi Verona Italy
  2. 2.CESPER, Centre for Research Study and Education of Family PaediatriciansUniversity of VeronaVerona Italy

Personalised recommendations